Stock listing

Evelo Biosciences, Inc.

Selected listing: EVLO · OTC · USD · US

Evelo Biosciences, Inc. (OTC:EVLO), Health Technology. Latest release Oct 18, 2023: Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study.

EVLO:OTCUSDUSUpdated October 2, 2026
Evelo Biosciences, Inc. logo
Ticker
OTC:EVLO
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD

About Evelo Biosciences, Inc.

The company focuses on developing therapies aimed at treating various diseases through its innovative approach to microbiome-based treatments. Evelo is committed to advancing its research and development efforts to improve patient outcomes.

Latest news from Evelo Biosciences, Inc.

Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study

October 18, 2023

What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock

May 17, 2023

All Evelo Biosciences, Inc. news →

Events

Replays

  • Evelo Biosciences, Inc. (EVLO) Q2 2022 Earnings Call

    Thu, Aug 11, 2022 · 07:30 AM ET

    Watch

  • Evelo Biosciences, Inc. (EVLO) Q4 2021 Earnings Call

    Thu, Mar 24, 2022 · 09:30 AM ET

    Watch

  • Evelo Biosciences, Inc. (EVLO) Q3 2021 Earnings Call

    Thu, Oct 28, 2021 · 08:30 AM ET

    Watch

Research Evelo Biosciences, Inc.

Evelo Biosciences, Inc. company profile

View the public company page for Evelo Biosciences, Inc. on 6ix.

Evelo Biosciences, Inc. news

Read company news and market updates connected to Evelo Biosciences, Inc..

Evelo Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Evelo Biosciences, Inc..